Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 2/20 | 0.53 |
| ▸ | PSMB5 | P28074 | 4/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | MMP8 | P22894 | 2/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | CPA1 | P15085 | 1/20 | 0.48 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.48 |
| ▸ | MMP14 | P50281 | 1/20 | 0.45 |
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | REN | P00797 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.43 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29535660 | 1.00 | CTSD (0.53) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL28563734 | 1.00 | CTSD (0.53) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL28560400 | 1.00 | CTSD (0.53) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL28559874 | 0.95 | FAAH (0.50) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL29603831 | 0.95 | FAAH (0.50) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL19586109 | 0.93 | PSMB5 (0.56) | CTSDPSMB5MMP9MMP8MMP2 | |
| SCHEMBL21772503 | 0.93 | PSMB5 (0.56) | CTSDPSMB5MMP9MMP8MMP2 | |
| SCHEMBL28523691 | 0.89 | CTSB (0.59) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL29535481 | 0.89 | CTSB (0.59) | CTSDPSMB5CTSBCTSKMMP9 | |
| SCHEMBL29530391 | 0.86 | PSMB5 (0.52) | CTSDPSMB5CTSBCTSKMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116492288-A | Preparation method and application of oral drug delivery system combining P-glycoprotein inhibitor and paclitaxel liposome | 首都医科大学 | 2023-07-28 | — | — | CN | claimed |
| CN-113105524-B | Polypeptide derivative copper complex, preparation method and application thereof, and anticancer drug | 首都医科大学 | 2022-05-17 | — | — | CN | claimed |
| CN-112691081-B | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2022-04-22 | — | — | CN | claimed |
| CN-113105524-A | Polypeptide derivative copper complex, preparation method and application thereof, and anticancer drug | 首都医科大学 | 2021-07-13 | — | — | CN | claimed |
| CN-112691081-A | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2021-04-23 | — | — | CN | claimed |
| CN-112279887-A | Amino acid derivative, preparation method and application thereof, anti-tumor micelle and preparation method thereof | 首都医科大学 | 2021-01-29 | — | — | CN | claimed |
| CN-116492288-A | Preparation method and application of oral drug delivery system combining P-glycoprotein inhibitor and paclitaxel liposome | 首都医科大学 | 2023-07-28 | — | — | CN | disclosed |
| CN-116492288-A | Preparation method and application of oral drug delivery system combining P-glycoprotein inhibitor and paclitaxel liposome | 首都医科大学 | 2023-07-28 | — | — | CN | disclosed |
| CN-113105524-B | Polypeptide derivative copper complex, preparation method and application thereof, and anticancer drug | 首都医科大学 | 2022-05-17 | — | — | CN | disclosed |
| CN-113105524-B | Polypeptide derivative copper complex, preparation method and application thereof, and anticancer drug | 首都医科大学 | 2022-05-17 | — | — | CN | disclosed |
| CN-112691081-B | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-112691081-B | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-112691081-B | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2022-04-22 | — | — | CN | disclosed |
| CN-113105524-A | Polypeptide derivative copper complex, preparation method and application thereof, and anticancer drug | 首都医科大学 | 2021-07-13 | — | — | CN | disclosed |
| CN-113105524-A | Polypeptide derivative copper complex, preparation method and application thereof, and anticancer drug | 首都医科大学 | 2021-07-13 | — | — | CN | disclosed |
| CN-112691081-A | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2021-04-23 | — | — | CN | disclosed |
| CN-112691081-A | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2021-04-23 | — | — | CN | disclosed |
| CN-112691081-A | Paclitaxel micelle based on (S) -2-decanoylamino-3- (1-naphthyl) propionyl-leucyl-valine | 首都医科大学 | 2021-04-23 | — | — | CN | disclosed |
| CN-112279887-A | Amino acid derivative, preparation method and application thereof, anti-tumor micelle and preparation method thereof | 首都医科大学 | 2021-01-29 | — | — | CN | disclosed |
| CN-112279887-A | Amino acid derivative, preparation method and application thereof, anti-tumor micelle and preparation method thereof | 首都医科大学 | 2021-01-29 | — | — | CN | disclosed |